Classics in Chemical Neuroscience: Selegiline, Isocarboxazid, Phenelzine, and Tranylcypromine.

Autor: Hoffman GR; Department of Cell and Developmental Biology, University of Colorado School of Medicine, 13001 E. 17th Place, Aurora, Colorado 80045, United States.; Department of Chemistry and Biochemistry, University of Colorado Colorado Springs, Colorado Springs, Colorado 80918, United States., Olson MG; Department of Cell and Developmental Biology, University of Colorado School of Medicine, 13001 E. 17th Place, Aurora, Colorado 80045, United States., Schoffstall AM; Department of Chemistry and Biochemistry, University of Colorado Colorado Springs, Colorado Springs, Colorado 80918, United States., Estévez RF; Department of Psychiatry, University of Central Florida, 4000 Central Florida Boulevard, Orlando, Florida 32816, United States.; Tampa Bay Neurobehavior Institute, 6311 Sheldon Road, Tampa Bay, Florida 33615, United States., Van den Eynde V; PsychoTropical Research, Bucasia, Queensland 4740, Australia.; Department of Psychiatry, RadboudUMC, 6500 Nijmegen, The Netherlands., Gillman PK; PsychoTropical Research, Bucasia, Queensland 4740, Australia., Stabio ME; Department of Cell and Developmental Biology, University of Colorado School of Medicine, 13001 E. 17th Place, Aurora, Colorado 80045, United States.

Publikováno v: ACS chemical neuroscience [ACS Chem Neurosci] 2023 Dec 06; Vol. 14 (23), pp. 4064-4075. Date of Electronic Publication: 2023 Nov 15.

Anticholinergic medication for antipsychotic-induced tardive dyskinesia.

Autor: Bergman H; Cochrane Response, Cochrane, St Albans House, 57-59 Haymarket, London, UK, SW1Y 4QX., Soares-Weiser K

Publikováno v: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2018 Jan 17; Vol. 1. Cochrane AN: CD000204. Date of Electronic Publication: 2018 Jan 17.

Response to "Sertraline and isocarboxazid cause a serotonin syndrome".

Autor: Kirrane R, Bodner R, Lynch T

Publikováno v: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 1995 Apr; Vol. 15 (2), pp. 144.

Evolution of ideas about the risk of tyramine syndrome developing during therapy with irreversible non-selective monoamine oxidase inhibitors (to the 70th anniversary of the first use of this group of antidepressants)

Autor: D. S. Danilov, M. Yu. Brovko

Publikováno v: Неврология, нейропсихиатрия, психосоматика, Vol 14, Iss 5, Pp 4-12 (2022)

We describe the history of studying of the problem of tyramine syndrome during the treatment with antidepressants, irreversible non-selective monoamine oxidase inhibitors. Data on clinical observations are presented. Early hypotheses of pathogenesis

Externí odkaz: https://doaj.org/article/8fbe0890e761401eb27ddc3e627e6fc5

[Combination of tricyclic antidepressants and MAOI in the depressions].

Autor: Abdala EN

Publikováno v: Acta psiquiatrica y psicologica de America latina [Acta Psiquiatr Psicol Am Lat] 1975 Mar; Vol. 21 (1), pp. 52-5.